MedTrace Logo

Child-Parent Familial Hypercholesterolemia Screening

NCT04529967 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2026-05-15

No results posted yet for this study

Summary

Child-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited premature coronary artery disease. The investigators assessed the efficacy and feasibility of such screening in primary care practice.

key scientific questions:

1. The 95th and 99th percentile of finger blood TC in children of 2 years old.
2. Mutations that contribute to high TC status ( serum TC \>99th percentiles) compared with international FH48 panel for FH genetic screening.

Conditions

  • Familial Hypercholesterolemia

Interventions

OTHER

no interventions

it is a observational study, do not have interventions.

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • LIling Qian, Master · Children's Hospital of Fudan University

  • Rui Dong, MD · Children's Hospital of Fudan University

Eligibility

Min Age
1 Year
Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04529967 on ClinicalTrials.gov